GAULE, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 204
EU - Europa 196
AS - Asia 55
SA - Sud America 1
Totale 456
Nazione #
US - Stati Uniti d'America 202
IT - Italia 79
CN - Cina 52
IE - Irlanda 36
SE - Svezia 28
FR - Francia 18
DE - Germania 14
FI - Finlandia 11
BE - Belgio 7
CA - Canada 2
GB - Regno Unito 2
IN - India 2
AT - Austria 1
CL - Cile 1
IR - Iran 1
Totale 456
Città #
Chandler 63
Dublin 36
Ashburn 27
Rome 11
Helsinki 10
Verona 9
Beijing 8
New York 8
Brussels 7
Jinan 7
Lawrence 7
Princeton 7
Sindelfingen 6
Taiyuan 6
Ann Arbor 5
Jacksonville 5
Treviso 5
Wilmington 5
Milan 4
Redmond 4
Tianjin 4
Dongguan 3
Frignano 3
Marsala 3
Shenyang 3
Taizhou 3
Bari 2
Bologna 2
Changsha 2
Fuzhou 2
Genoa 2
Gera 2
Guangzhou 2
Pieve Emanuele 2
Scandicci 2
Seattle 2
Southend 2
Toronto 2
Turin 2
Varese 2
Vicenza 2
Washington 2
Zhengzhou 2
Alfonsine 1
Clearwater 1
Haikou 1
Hanover 1
Houston 1
Kashan 1
Landshut 1
Lappeenranta 1
Lutzingen 1
Ningbo 1
Sacramento 1
San Diego 1
Xiangfen 1
Totale 306
Nome #
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 83
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 73
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 62
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 46
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 46
KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities 45
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 45
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 26
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 22
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 22
Totale 470
Categoria #
all - tutte 1.828
article - articoli 1.828
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.656


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 0 0 4
2020/202147 2 3 1 4 2 19 0 9 0 0 3 4
2021/202285 8 28 4 9 2 1 1 3 5 2 4 18
2022/2023200 7 23 11 30 12 50 0 18 33 5 6 5
2023/2024134 6 11 13 18 23 23 34 6 0 0 0 0
Totale 470